Induction of Alternative Splicing and Inhibition of Activity of Telomerase Catalytic Subunit by Apoptotic Endonuclease EndoG in Human T, B, and NK Cells


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The effect of apoptotic endonuclease EndoG on alternative splicing of mRNA of human telomerase catalytic subunit hTERT (human telomerase reverse transcriptase) and telomerase activity in normal human lymphocytes were studied. Human CD4+, CD8+, B, and NK cells were transfected with a plasmid pEndoG-GFP containing EndoG gene or control plasmid pGFP. The levels of mRNA of EndoG or hTERT splicing variants were analyzed by real-time PCR. Protein content was assessed by Western blotting. Telomerase activity was measured by the telomere repeats amplification protocol. EndoG overexpression reduced the expression of active full-length hTERT and increased the expression of inactive splice variant. Shifted balance of hTERT splice variants in cells led to a significant decrease in telomerase activity within 72 h after transfection.

About the authors

D. D. Zhdanov

Laboratory of Medical Biotechnology, V. N. Orekhovich Research Institute of Biomedical Chemistry

Author for correspondence.
Email: zhdanovdd@mail.ru
Russian Federation, Moscow

Yu. A. Gladilina

Laboratory of Medical Biotechnology, V. N. Orekhovich Research Institute of Biomedical Chemistry

Email: zhdanovdd@mail.ru
Russian Federation, Moscow

M. V. Pokrovskaya

Laboratory of Medical Biotechnology, V. N. Orekhovich Research Institute of Biomedical Chemistry

Email: zhdanovdd@mail.ru
Russian Federation, Moscow

S. S. Aleksandrova

Laboratory of Medical Biotechnology, V. N. Orekhovich Research Institute of Biomedical Chemistry

Email: zhdanovdd@mail.ru
Russian Federation, Moscow

D. V. Grishin

Laboratory of Medical Biotechnology, V. N. Orekhovich Research Institute of Biomedical Chemistry

Email: zhdanovdd@mail.ru
Russian Federation, Moscow

O. V. Podobed

Laboratory of Medical Biotechnology, V. N. Orekhovich Research Institute of Biomedical Chemistry

Email: zhdanovdd@mail.ru
Russian Federation, Moscow

N. N. Sokolov

Laboratory of Medical Biotechnology, V. N. Orekhovich Research Institute of Biomedical Chemistry

Email: zhdanovdd@mail.ru
Russian Federation, Moscow


Copyright (c) 2018 Springer Science+Business Media, LLC, part of Springer Nature

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies